Always Remember - Buy The Dip

Sentiment Analysis For RGLS

The news is currently generally neutral for RGLS.

Based on TextBlob analysis of Yahoo! Finance news summaries for RGLS on 2015-09-16.

Yahoo! Finance News for RGLS

Earnings Reported After The Bell Aug. 4
Earnings Reported After The Bell Aug. 4

Wednesday 7/22 Insider Buying Report: RGLS, OMN
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy they expect to make money. So let's look at two noteworthy recent insider buys. At Regulus Therapeutics

Health Care Sector Update for 06/09/2015: RGLS, RDHL, AXN
Top health care stocks JNJ flat PFE flat ABT flat MRK flat AMGN flat Health care shares were mainly unchanged in pre market trading Tuesday. Aoxing Pharmaceutical ( AXN ) shares surged pre bell, putting the stock on track

Health Care Sector Update for 06/04/2015: RGLS, NVGN, STEM
Top health care stocks JNJ flat PFE flat ABT flat MRK flat AMGN flat Health care shares were mainly flat in pre market trading Thursday. Regulus Therapeutics ( RGLS ) Thursday reported dosing has begun in a first in

Why Shares in Regulus Therapeutics Inc. Are Tumbling
Although we don't believe intiming the market or panicking over market movements, we do like to keep an eye on big changes just in case they're material to our investing thesis.

Becton, Dickinson (BDX) Q2 Earnings: What to Expect? - Analyst Blog
Becton, Dickinson and Company BDX is set to report second quarter fiscal 2015 earnings results on May 7. Last quarter, Becton, Dickinson, popularly known as BD, beat the Zacks Consensus Estimate by almost 7% (10 cents). We note that

Will DENTSPLY (XRAY) Disappoint This Earnings Season? - Analyst Blog
DENTSPLY International Inc. XRAY is scheduled to announce first quarter 2015 earnings results on May 6. Last quarter, the company missed the Zacks Consensus Estimate by a penny (1.64%). However, we note that DENTSPLY has outperformed the Zacks Consensus

Pacific Biosciences: What to Look for This Quarter - Analyst Blog
Pacific Biosciences of California, Inc.PACB is scheduled to report first quarter 2015 earnings results on May 5. Last quarter, the company reported loss of 26 cents per share which was in line with the Zacks Consensus Estimate. The average

Is it a Miss for TrovaGene (TROV) This Earnings Season? - Analyst Blog
TrovaGene Inc. TROV is scheduled to report first quarter 2015 earnings results on May 5. Last quarter, the company reported a loss of 26 cents per share which was wider than the Zacks Consensus Estimate by 4 cents (18.2%).

Monday's ETF Movers: GDXJ, XBI
In trading on Monday, the Junior Gold Miners ETF ( GDXJ ) is outperforming other ETFs, up about 3.2% on the day. Components of that ETF showing particular strength include shares of Coeur Mining ( CDE ), up about

The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead - Press Releases
For Immediate Release Chicago, IL April 09, 2015 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks

Why Regulus Therapeutics Inc. Shares Soared Higher Today
Although we don't believe intiming the market or panicking over market movements, we do like to keep an eye on big changes just in case they're material to our investing thesis.

Health Care Sector Update for 04/08/2015: RGLS,AZN,EYES,AEMD
Top Health Care Stocks JNJ +0.02% PZE +0.32% MRK +0.93% ABT +0.12% AMGN +1.47% Healthcare stocks were mostly higher, with the NYSE Healthcare Sector Index rising 0.7% and the S&P Healthcare Index posting an 0.8% gain. In company news,

Health Care Sector Update for 04/08/2015: RGLS, OCUL, ACT
Top Health care stocks JNJ flat PFE +0.3% ABT flat MRK +1.0% AMGN flat Health care shares were generally unchanged in pre market trade Wednesday. In health care stocks news, Regulus Therapeutics ( RGLS ) shares rose in Wednesday's

Health Care Sector Update for 03/25/2015: ALDX, DGX, RGLS
Top Health care stocks JNJ flat PFE flat ABT flat MRK +1.3% AMGN flat Health care shares were generally unchanged in pre market trade Wednesday. In health care stocks news, Story Aldeyra Therapeutics ( ALDX ) received a buy

Whoa, a Profit for Isis Pharmaceuticals Inc.
Isis Pharmaceuticals reported a $31 million profit in the fourth quarter. That's right, profit. Source Isis Pharmaceuticals. No, Kynamro, the only drug Isis has on the market, didn't become